RT Journal Article
T1 Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions.
A1 Caracciolo, Alessandro
A1 Mazzone, Paolo
A1 Laterra, Giulia
A1 Garcia-Ruiz, Victoria
A1 Polimeni, Alberto
A1 Galasso, Salvatore
A1 Saporito, Francesco
A1 Carerj, Scipione
A1 D'Ascenzo, Fabrizio
A1 Marquis-Gravel, Guillaume
A1 Giustino, Gennaro
A1 Costa, Francesco
K1 antiplatelet
K1 coronary artery disease
K1 dual antiplatelet therapy
K1 structural heart disease
AB Percutaneous cardiovascular interventions have changed dramatically in recent years, and the impetus given by the rapid implementation of novel techniques and devices have been mirrored by a refinement of antithrombotic strategies for secondary prevention, which have been supported by a significant burden of evidence from clinical studies. In the current manuscript, we aim to provide a comprehensive, yet pragmatic, revision of the current available evidence regarding antithrombotic strategies in the domain of percutaneous cardiovascular interventions. We revise the evidence regarding antithrombotic therapy for secondary prevention in coronary artery disease and stent implantation, the complex interrelation between antiplatelet and anticoagulant therapy in patients undergoing percutaneous coronary intervention with concomitant atrial fibrillation, and finally focus on the novel developments in the secondary prevention after structural heart disease intervention. A special focus on treatment individualization is included to emphasize risk and benefits of each therapeutic strategy.
SN 2077-0383
YR 2019
FD 2019-11-19
LK http://hdl.handle.net/10668/14725
UL http://hdl.handle.net/10668/14725
LA en
DS RISalud
RD Apr 9, 2025